• Je něco špatně v tomto záznamu ?

Protein expression of ABCC2 and SLC22A3 associates with prognosis of pancreatic adenocarcinoma

L. Cervenkova, O. Vycital, J. Bruha, J. Rosendorf, R. Palek, V. Liska, O. Daum, B. Mohelnikova-Duchonova, P. Soucek,

. 2019 ; 9 (1) : 19782. [pub] 20191224

Jazyk angličtina Země Velká Británie

Typ dokumentu klinické zkoušky, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20028700

ATP-binding cassette (ABC) and solute carrier (SLC) transporters translocate diverse substances across cellular membranes and their deregulation may cause drug resistance of cancers. This study investigated significance of protein expression and cellular localization of the previously suggested putative prognostic markers ABCC2 and SLC22A3 in pancreatic cancer patients. Protein localization and brush border staining intensity of ABCC2 and SLC22A3 was assessed in tumor tissue blocks of 65 pancreatic cancer patients and associated with clinical data and survival of patients with regard to therapy. Negative SLC22A3 brush border staining in pancreatic tumors significantly increased the risk of both disease progression and patient´s death in univariate analyses. Multivariate analyses confirmed the association of SLC22A3 expression with progression-free survival of patients. A subgroup analysis of patients treated with regimens based on nucleoside analogs suggested that patients with negative brush border staining or apical localization of SLC22A3 in tumor cells have worse overall survival. The combination of positive ABCC2 and negative SLC22A3 brush border staining predicted worst overall survival and patients with positive brush border staining of both proteins had best overall and progression-free survival. The present study shows for the first time that the protein presence and to some extent also localization of SLC22A3 significantly associate with prognosis of pancreatic cancer in both unstratified and chemotherapy-treated patients. The combination of ABCC2 and SLC22A3 brush border staining also needs further attention in this regard.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20028700
003      
CZ-PrNML
005      
20210114154755.0
007      
ta
008      
210105s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41598-019-56059-w $2 doi
035    __
$a (PubMed)31874997
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Cervenkova, Lenka $u Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. Department of Pathology, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
245    10
$a Protein expression of ABCC2 and SLC22A3 associates with prognosis of pancreatic adenocarcinoma / $c L. Cervenkova, O. Vycital, J. Bruha, J. Rosendorf, R. Palek, V. Liska, O. Daum, B. Mohelnikova-Duchonova, P. Soucek,
520    9_
$a ATP-binding cassette (ABC) and solute carrier (SLC) transporters translocate diverse substances across cellular membranes and their deregulation may cause drug resistance of cancers. This study investigated significance of protein expression and cellular localization of the previously suggested putative prognostic markers ABCC2 and SLC22A3 in pancreatic cancer patients. Protein localization and brush border staining intensity of ABCC2 and SLC22A3 was assessed in tumor tissue blocks of 65 pancreatic cancer patients and associated with clinical data and survival of patients with regard to therapy. Negative SLC22A3 brush border staining in pancreatic tumors significantly increased the risk of both disease progression and patient´s death in univariate analyses. Multivariate analyses confirmed the association of SLC22A3 expression with progression-free survival of patients. A subgroup analysis of patients treated with regimens based on nucleoside analogs suggested that patients with negative brush border staining or apical localization of SLC22A3 in tumor cells have worse overall survival. The combination of positive ABCC2 and negative SLC22A3 brush border staining predicted worst overall survival and patients with positive brush border staining of both proteins had best overall and progression-free survival. The present study shows for the first time that the protein presence and to some extent also localization of SLC22A3 significantly associate with prognosis of pancreatic cancer in both unstratified and chemotherapy-treated patients. The combination of ABCC2 and SLC22A3 brush border staining also needs further attention in this regard.
650    12
$a adenokarcinom $x metabolismus $x mortalita $x patologie $7 D000230
650    _2
$a senioři $7 D000368
650    _2
$a přežití bez známek nemoci $7 D018572
650    _2
$a ženské pohlaví $7 D005260
650    12
$a regulace genové exprese u nádorů $7 D015972
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a proteiny spojené s mnohočetnou rezistencí k lékům $x biosyntéza $7 D027425
650    _2
$a nádorové proteiny $x biosyntéza $7 D009363
650    _2
$a proteiny přenášející organické kationty $x biosyntéza $7 D027701
650    12
$a nádory slinivky břišní $x metabolismus $x mortalita $x patologie $7 D010190
650    _2
$a míra přežití $7 D015996
655    _2
$a klinické zkoušky $7 D016430
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Vycital, Ondrej $u Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. Deparment of Surgery, Faculty Hospital and Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
700    1_
$a Bruha, Jan $u Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. Deparment of Surgery, Faculty Hospital and Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
700    1_
$a Rosendorf, Jachym $u Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. Deparment of Surgery, Faculty Hospital and Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
700    1_
$a Palek, Richard $u Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. Deparment of Surgery, Faculty Hospital and Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
700    1_
$a Liska, Vaclav $u Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. Deparment of Surgery, Faculty Hospital and Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
700    1_
$a Daum, Ondrej $u Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. Department of Pathology, Faculty Hospital and Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
700    1_
$a Mohelnikova-Duchonova, Beatrice $u Department of Oncology and Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
700    1_
$a Soucek, Pavel $u Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. pavel.soucek@lfp.cuni.cz.
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 9, č. 1 (2019), s. 19782
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31874997 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210114154752 $b ABA008
999    __
$a ok $b bmc $g 1609035 $s 1119880
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 9 $c 1 $d 19782 $e 20191224 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
LZP    __
$a Pubmed-20210105

Najít záznam

Citační ukazatele

Možnosti archivace